LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 27.11 | 771.67 | 1394 | 2675 | 0.5211 | 0.3906 | MN20160304_L01 | I17 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 27.11 | 771.67 | 1264 | 2675 | 0.4725 | 0.3167 | MN20160304_L01 | I18 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 29.33 | 771.67 | 1316 | 2939 | 0.4477 | 0.3187 | MN20160304_L01 | F21 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 29.33 | 771.67 | 1456 | 2939 | 0.4953 | 0.3897 | MN20160304_L01 | I17 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 29.33 | 771.67 | 1321 | 2939 | 0.4494 | 0.3213 | MN20160304_L01 | I18 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 31.55 | 771.67 | 1344 | 3196 | 0.4204 | 0.3107 | MN20160304_L01 | F21 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 31.55 | 771.67 | 1531 | 3196 | 0.4789 | 0.3967 | MN20160304_L01 | I17 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 31.55 | 771.67 | 1358 | 3196 | 0.4248 | 0.3174 | MN20160304_L01 | I18 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 33.78 | 771.67 | 1413 | 3499 | 0.4038 | 0.3196 | MN20160304_L01 | F21 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 33.78 | 771.67 | 1614 | 3499 | 0.4612 | 0.4026 | MN20160304_L01 | I17 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 33.78 | 771.67 | 1431 | 3499 | 0.4089 | 0.3273 | MN20160304_L01 | I18 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 36.00 | 771.67 | 1476 | 3884 | 0.3800 | 0.3207 | MN20160304_L01 | F21 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 36.00 | 771.67 | 1674 | 3884 | 0.4309 | 0.3939 | MN20160304_L01 | I17 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 36.00 | 771.67 | 1511 | 3884 | 0.3890 | 0.3340 | MN20160304_L01 | I18 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 38.22 | 771.67 | 1507 | 4299 | 0.3505 | 0.3101 | MN20160304_L01 | F21 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 38.22 | 771.67 | 1769 | 4299 | 0.4114 | 0.3976 | MN20160304_L01 | I17 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 38.22 | 771.67 | 1597 | 4299 | 0.3714 | 0.3411 | MN20160304_L01 | I18 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 40.44 | 771.67 | 1544 | 4738 | 0.3259 | 0.3033 | MN20160304_L01 | F21 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 40.44 | 771.67 | 1808 | 4738 | 0.3816 | 0.3843 | MN20160304_L01 | I17 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 40.44 | 771.67 | 1674 | 4738 | 0.3533 | 0.3442 | MN20160304_L01 | I18 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 42.67 | 771.67 | 1569 | 5155 | 0.3043 | 0.2956 | MN20160304_L01 | F21 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 42.67 | 771.67 | 1863 | 5155 | 0.3613 | 0.3794 | MN20160304_L01 | I17 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 42.67 | 771.67 | 1669 | 5155 | 0.3237 | 0.3252 | MN20160304_L01 | I18 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 44.89 | 771.67 | 1598 | 5541 | 0.2884 | 0.2917 | MN20160304_L01 | F21 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 44.89 | 771.67 | 1907 | 5541 | 0.3441 | 0.3745 | MN20160304_L01 | I17 |